Lipoprotein(a): The Genetic Cholesterol Risk Marker

This article is part of our Preventive Cardiology Guide, which explains how early detection and risk assessment help reduce cardiovascular disease risk.

Most cardiovascular risk discussions focus on cholesterol levels such as LDL cholesterol. However, some individuals develop cardiovascular disease despite having normal cholesterol levels.

One reason may be Lipoprotein(a), often abbreviated Lp(a). Lp(a) is a genetically determined lipoprotein that can contribute to atherosclerosis and cardiovascular disease.

What Is Lipoprotein(a)?

Lipoprotein(a) is a lipoprotein particle similar to LDL cholesterol but with an additional protein attached called apolipoprotein(a).

This additional component changes how the particle behaves in the bloodstream and may increase its ability to contribute to plaque formation.

Because each Lp(a) particle also contains ApoB, it is considered one of the atherogenic lipoproteins involved in cardiovascular disease.

Learn more about atherogenic particles in our article on ApoB Explained.

Why Lp(a) Is Considered a Genetic Risk Factor

Unlike LDL cholesterol, which is strongly influenced by diet and lifestyle, Lp(a) levels are largely determined by genetics.

Many individuals inherit elevated Lp(a) levels and may be unaware of their increased cardiovascular risk.

Because Lp(a) levels remain relatively stable throughout life, testing once in adulthood can often provide insight into inherited cardiovascular risk.

How Lipoprotein(a) Contributes to Atherosclerosis

Lipoprotein(a) may contribute to cardiovascular disease through several mechanisms.

These include:

• promoting plaque formation in arteries
• increasing inflammatory activity within arterial walls
• interfering with normal clot breakdown mechanisms

These processes can contribute to the development of atherosclerosis over time.

Lipoprotein(a) and Cardiovascular Screening

Because Lp(a) levels are inherited and not always reflected in standard cholesterol tests, some preventive cardiology approaches include measuring Lp(a) at least once in adulthood.

This information can provide additional insight into cardiovascular risk.

Imaging tools such as coronary artery calcium scoring may help identify whether plaque has already developed in the coronary arteries.

Lipoprotein(a) and Preventive Cardiology

Preventive cardiology focuses on identifying cardiovascular risk before symptoms develop.

Understanding genetic risk markers such as Lp(a) may help provide a more complete picture of cardiovascular health.

Learn more in our guide to Preventive Cardiology.

Frequently Asked Questions

What does Lipoprotein(a) measure?

Lipoprotein(a) measures the concentration of Lp(a) particles in the bloodstream, which are genetically influenced lipoproteins associated with cardiovascular risk.

Is Lp(a) included in a standard cholesterol test?

No. Lipoprotein(a) is not typically included in standard lipid panels and usually requires a specific blood test.

Can lifestyle changes lower Lp(a)?

Lp(a) levels are largely genetically determined and are typically less influenced by lifestyle compared with LDL cholesterol.

Why is Lp(a) important in preventive cardiology?

Identifying inherited cardiovascular risk markers such as Lp(a) may help clinicians better understand long-term cardiovascular risk.